David R. Bauer
Lawyers
Filters
Eli Lilly €1.8 billion and £250 million notes offering
The investment-grade offering included the company’s inaugural sustainability bonds
Maravai LifeSciences $1 billion secondary offering
The shares are listed on the Nasdaq Global Select Market
TBCASoft $25 million Series B equity funding round
We advised Naver Financial on its strategic investment in TBCASoft
Adagio Therapeutics $356 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Nurix Therapeutics $150 million at-the-market offering
We advised the sales agent on the stock offering
RxSight $117.6 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Tenaya Therapeutics $207 million IPO
We advised the underwriters on the IPO and Nasdaq listing
SOPHiA GENETICS $234 million IPO and $20 million private placement
We advised SOPHiA GENETICS on its IPO, Nasdaq listing and concurrent private placement
TScan Therapeutics $100 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Acutus Medical $77 million follow-on offering
We advised Acutus Medical on the SEC-registered stock offering